Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Ferrioxamine excretion in iron-loaded man

Journal Article · · Blood; (United States)
OSTI ID:6701993
Factors affecting iron excretion after subcutaneous desferrioxamine infusion were evaluated in individuals with iron overload. Urinary iron varied directly, whereas stool iron varied inversely with the level of erythropoiesis. Ascorbic acid greatly enhanced urinary iron excretion but had a less constant effect on stool iron. Stool iron losses contributed a greater proportion of total iron excretion at higher chelator dosage. These studies indicate the importance of biliary iron excretion in monitoring the effectiveness of desferrioxamine. They also suggest that large chelator doses may remove established iron overload much more rapidly than has previously been realized.
OSTI ID:
6701993
Journal Information:
Blood; (United States), Journal Name: Blood; (United States) Vol. 60:2; ISSN BLOOA
Country of Publication:
United States
Language:
English